Skin AnarchyHow Lash Care Became Its Own Category With Dr. Michael Brinkenhoff of RevitaLash CosmeticsFunding A New Cancer Drug
20:40–22:47 · 127s
He reveals channeling RevitaLash philanthropy directly into a biotech developing a non-toxic therapy that could treat many cancers—aiming to move lab breakthroughs to patients.